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AbstrACt
Objectives Redispensing by pharmacies of medication 
unused by another patient could contribute to optimal 
use of healthcare resources. This study aimed to assess 
patient willingness to use medication returned by another 
patient and patient characteristics associated with this 
willingness.
Design Cross-sectional survey.
setting A total of 41 community and 5 outpatient 
pharmacies in the Netherlands.
Participants Total of 2215 pharmacy visitors.
Primary and secondary outcome measures Patients 
completed a questionnaire regarding their willingness 
to use medication returned unused to the pharmacy 
by another patient, assuming quality was guaranteed. 
Secondary outcome measures included patient 
sociodemographic characteristics that were associated 
with patient willingness, analysed using logistic regression 
analysis and reported as ORs with 95% CIs.
results Of the 2215 patients (mean (SD) age 50.6(18.0) 
years; 61.4% female), 61.2% were willing to use 
medication returned unused to the pharmacy by another 
patient. Patients who were unwilling mostly found it risky. 
Men were more willing to use returned medication (OR 1.3 
95% CI 1.1 to 1.6), as did patients with a high educational 
level (OR 1.8 95% CI 1.3 to 2.5), those who regularly use 
1–3 medications (OR 1.3 95% CI 1.1 to 1.7), those who 
returned medication to the pharmacy for disposal (OR 
1.5 95% CI 1.0 to 2.3) and those who ever had unused 
medication themselves (OR 1.3 95% CI 1.1 to 1.6)). 
Patients with non-Dutch cultural background were less 
willing to use returned medication (OR 0.395% CI 0.3 to 
0.4)).
Conclusions When quality is guaranteed, a substantial 
proportion of patients are willing to use medication 
returned unused to the pharmacy by another patient. This 
suggests that implementation of redispensing may be 
supported by patients.
IntrODuCtIOn
Up to one-third of patients do not use all 
medication dispensed by their pharmacy,1 2 
leading to a waste of healthcare resources and 
potentially environmental pollution. Previous 
studies reported that 20%–90% of medi-
cation dispensed but unused by patients 
still are in their unopened and intact 
packaging.3–7 Patients either dispose these 
unused medication at home (eg, household 
waste) or return these to pharmacies who 
discard these as special waste.8 Redispensing 
these unused medication could contribute 
to waste-reduction. Although medication 
that remain unused by patients in healthcare 
institutions are occasionally redispensed to 
patients who cannot afford healthcare,9 10 
there is no standard practice,11 primarily due 
to uncertainties surrounding the quality 
assurance of returned medication and legal 
constraints including product liability.
Stakeholders are positive regarding imple-
mentation of a redispensing process;12 13 
however, they explicitly stated that successful 
implementation relies heavily on patient 
support. A qualitative study with 19 partici-
pants from the UK showed that people would 
generally agree to use redispensed medi-
cation if safety and product quality is guar-
anteed.14 Other surveys from the UK and 
the Netherlands showed that people would 
accept redispensed medication.15–17 However, 
these studies involved small study populations 
and did not determine which patient groups 
would be more or less willing to use redis-
pensed medication. This study therefore aims 
to assess patient willingness to use medication 
returned unused to the pharmacy by another 
patient and patient characteristics associated 
with this willingness.
strengths and limitations of this study
 ► This study included a large patient sample to assess 
their willingness to use redispensed medication.
 ► Patient groups who were more or less willing were 
identified.
 ► Patient willingness may not be identical if redis-
pensing is implemented in practice.
 ► In-depth information on patient barriers and facilita-
tors were not identified.
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MethODs
A cross-sectional anonymous survey was conducted in 
41 community pharmacies and five outpatient pharma-
cies, involved in the Utrecht Pharmacy Practice network 
for Education and Research (UPPER) network of the 
Utrecht University,18 between April and December 2014 
in the Netherlands (approved by the UPPER Institutional 
Review Board of the Utrecht University (UP1408)).
In each participating pharmacy, approximately consec-
utive 50 adult (≥18 years and able to communicate in 
Dutch) visitors were approached by pharmacy students 
to complete a questionnaire in writing while waiting or 
orally in case of returning medication for disposal. Visi-
tors were asked about their willingness to use medication 
returned unused to the pharmacy by another patient if 
the quality was guaranteed, with multiple answer options: 
‘yes, it is a shame to destroy good-quality medication’; 
‘yes, if this medication is cheaper or free’; ‘no, I don’t 
want secondhand medication’; ‘no, I find it risky’ or 
‘other’. Besides registering their sociodemographic char-
acteristics age, gender, educational level (‘low’/‘medi-
um’/‘high’) and cultural background (‘Dutch’/‘other’), 
visitors were asked whether they had ever had unused 
medication themselves (‘yes’/‘no’/‘don’t know’), and 
the number of prescription medications they regu-
larly use (‘none’/‘1–3’/‘≥4’). The questionnaire was 
composed through discussion with the research group, 
pilot tested among patients in two community pharma-
cies on inclusion and patients’ understanding. It was 
feasible to include 50 patients per pharmacy per day and 
no adjustments to the questionnaire were made. The 
questionnaire was also used in another study that assessed 
unused medication returned to community pharmacies. 
Participating patients who were returning unused medi-
cation for disposal were asked additional questions as part 
of a larger study.7
Data were presented in proportions or means with SD. 
Associations between patient characteristics and willing-
ness to use returned medication (answers categorised 
into yes/no) were analysed in STATA V.13, using univar-
iate and multivariate logistic regression analyses (full 
model with complete cases), reported as ORs with 95% 
CIs. To assess if hierarchical data structure (patients clus-
tered within pharmacy) influenced our outcomes, multi-
level sensitivity analysis was conducted.
Patient involvement
Patients were not involved in the design of the study.
results
A total of 2215 patients (mean (SD) age 50.6 (18.0) 
years, 61.4% female) participated, 88.8% of whom were 
community pharmacy visitors. Of all patients, 142 (6.4%) 
were returning medication for disposal. Most patients had 
a Dutch cultural background (77.8%), a medium educa-
tional level (48.2%) and regularly used 1–3 prescription 
medications (45.9%). A total of 1436 (64.8%) patients 
had ever had unused medication themselves.
Over half of patients were willing to use medication 
returned unused to the pharmacy by another patient 
(61.2%, table 1). Of these, 88.4% was willing because they 
found it a shame to destroy good-quality medication and 
19.9% if these were cheaper or free. Some patients explic-
itly reported that they were only willing if these were 
returned in original, unopened packages. Of patients who 
were not willing to use returned medication, most found 
it risky (64.1%) or did not wanted secondhand medica-
tion (41.1%). Other reasons included not knowing how 
medication were handled and stored by other patients 
and how quality could be monitored.
Men were more willing to use returned medication 
(OR 1.3 95% CI 1.1 to 1.6), as did patients with a high 
educational level (OR 1.8 95% CI 1.3 to 2.5, table 2). 
Furthermore, patients who regularly use 1–3 prescription 
medications were more willing to use returned medica-
tion (OR 1.3 95% CI 1.1 to 1.7), also patients who were 
questioned as they returned medication (OR 1.5 95% CI 
1.0 to 2.3) and patients who had ever had unused medica-
tion themselves (OR 1.3 95% CI 1.1 to 1.6). Patients with 
non-Dutch cultural background were less willing to use 
returned medication (OR 0.3 95% CI 0.3 to 0.4). Age and 
type of pharmacy were not associated with patient will-
ingness to use returned medication. Sensitivity analysis 
demonstrated similar associations.
DIsCussIOn
This study shows that a substantial proportion of patients 
are willing to use medication returned to the pharmacy 
by another patient when the quality is guaranteed. Males, 
patients with a high education, those regularly using 
medication, those returning medication to the pharmacy 
for disposal and those who ever had unused medication 
themselves were in particular more willing to use returned 
medication.
Table 1 Patient willingness to use medication returned 




  Yes, it is a shame to destroy good-quality 
medication
1198 (88.4)
  Yes, if this medication is cheaper or free 269 (19.9)
  Other 35 (2.6)
Unwilling* 869 (39.2)
  No, I find it risky 557 (64.1)
  No, I don’t want secondhand medication 357 (41.1)
  Other 8 (0.9)
*Patients could report multiple answers.
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Worldwide, increased attention is being paid to sustain-
able environment, including green pharmacy practices, 
of which redispensing represents an important compo-
nent.19 Patient support for redispensing is crucial.12 13 
Our findings in a large patient sample are consistent with 
previous, smaller, studies, which found that 50%–95% 
of patients would accept medication returned by other 
patients.15–17 We found that patients who were less 
supportive primarily had concerns about risks, including 
tampering with the medication, inadequate storage condi-
tions and reliability of the quality assurance. Few studies 
have identified patient barriers and facilitators to redis-
pensing unused medication by pharmacies. Almahad 
et al14 interviewed 19 patients ≥40 years and concluded 
that many are in favour of redispensing because it could 
reduce the negative consequences of waste. Potential 
disadvantages identified by these patients included 
improper storage of medication, medication errors intro-
duced by patients and counterfeit medication entering 
the system. We found that less willing patients had more 
often non-Dutch cultural backgrounds. Before consid-
ering implementation of redispensing, concerns of less 
willing patients should be identified in-depth and barriers 
should be overcome. Interventions aiming at behavioural 
changes may be required for ultimately increasing patient 
support, such as raising awareness on waste and using 
(monetary) incentives. Future studies should also identify 
the type of medication packages that can be redispensed 













  Female 1320 (61.8) 782 (59.7) 538 (65.1) Ref. Ref.
  Male 816 (38.2) 528 (40.3) 288 (34.9) 1.3 (1.1 to 1.5) 1.3 (1.1 to 1.6)
Age
  18–40 716 (33.5) 402 (30.7) 314 (38.0) Ref. Ref.
  41–65 887 (41.5) 580 (44.3) 307 (37.2) 1.5 (1.2 to 1.8) 1.2 (0.9 to 1.5)
  >65 533 (25.0) 328 (25.0) 205 (24.8) 1.2 (1.0 to 1.6) 0.8 (0.6 to 1.1)
Educational level
  Low 250 (11.7) 124 (9.4) 126 (15.2) Ref. Ref.
  Medium 1048 (49.1) 618 (47.2) 430 (52.1) 1.5 (1.1 to 1.9) 1.3 (0.9 to 1.7)
  High 838 (39.2) 568 (43.4) 270 (32.7) 2.1 (1.6 to 2.8) 1.8 (1.3 to 2.5)
Cultural background
  Dutch 1664 (77.9) 1132 (86.4) 532 (64.4) Ref. Ref.
  Other 472 (22.1) 178 (13.6) 294 (35.6) 0.3 (0.2 to 0.4) 0.3 (0.3 to 0.4)
Medications regularly used
  None 572 (26.8) 320 (24.4) 252 (30.5) Ref. Ref.
  1–3 971 (45.4) 616 (47.0) 355 (43.0) 1.4 (1.1 to 1.7) 1.3 (1.1 to 1.7)
≥4 593 (27.8) 374 (28.6) 219 (26.5) 1.3 (1.1 to 1.7) 1.3 (1.0 to 1.7)
Type of pharmacy
  Community 1891 (88.5) 1146 (87.5) 745 (90.2) Ref. Ref.
  Outpatient 245 (11.5) 164 (12.5) 81 (9.8) 1.3 (1.0 to 1.7) 1.2 (0.9 to 1.6)
Returning medication
  No 2000 (93.6) 1210 (92.4) 790 (95.6) Ref. Ref.
  Yes 136 (6.4) 100 (7.6) 36 (4.4) 1.8 (1.2 to 2.7) 1.5 (1.0 to 2.3)
Ever having any unused medication
  No
  Yes 710 (33.2) 393 (30.0) 317 (38.4) Ref. Ref.
  Don’t know 1388 (65.0) 905 (69.1) 483 (58.5) 1.5 (1.3 to 1.8) 1.3 (1.1 to 1.6)
38 (1.8) 12 (0.9) 26 (3.2) – –
Significant associations are shown in bold.
*Multivariate logistic regression analysis was conducted.
†For 79 (3.6%) patients, sociodemographic data was missing. Associations between patient characteristics and willingness to use returned 
medication were analysed for the remaining 2136 patients.
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from a patient perspective, for instance, original manu-
facturer’s packaging or also single blisters.
Although patients were found supportive of redis-
pensing, implementation may not be cost-beneficial for 
all types of medication. In a micro-costing study, all phar-
macy’s additional process steps that are required to redis-
pense unused medication in the pharmacy, including 
direct (labour and material) and indirect costs, were 
quantified (Bekker, accepted)20. The outcomes showed 
that redispensing is most cost-beneficial if applied to 
expensive medication. For low-cost medication, paying 
for the additional processing to guarantee the quality 
of returned medication will not outweigh the additional 
costs. To this end, redispensing may only be implemented 
for expensive medication. However, these substantially 
contribute to pharmaceutical spending, and if patients 
discontinue therapy frequently unused, expensive medi-
cation remains unused.3 Implementing a redispensing 
process for expensive medication could lead to substan-
tial cost savings.
Some patients were only willing to use redispensed 
medication if this were for cheaper or for free. Barriers 
may arise at providing redispensed medication at lower 
cost, because this may implicate a lower quality and could 
lead to lower adherence. Furthermore, if medications are 
provided at lower cost this will also influence the cost-ben-
efit ratio, that will presumably increase, thereby lowering 
the types of medications that can be redispensed from an 
economical point of view.’
Concerns exist about increased risk of counterfeit medi-
cation entering the pharmaceutical supply and use chain 
during redispensing.14 This will be tackled by the Euro-
pean Union directives 2011/62/EU and EU2016/161, 
which demand that manufacturers add tamper indicators 
and unique identification codes to the outer packaging of 
medication from 2019 to minimise the risk of falsification. 
Each unique package will be registered in a large reposi-
tory, then during the dispensing to the patient its authen-
ticity will be verified and the package will be unsubscribed 
from the database. Unfortunately, this directive will likely 
hamper redispensing, as returned medication cannot 
re-enter the database and thus cannot be verified during 
the subsequent redispensing. How to tackle this barrier 
should be further explored. For example, authorised 
persons such as pharmacists may be able to re-subscribe 
returned medication into the database.
This study captured the willingness on redispensing in a 
large patient sample. However, we cannot assure that this 
is identical if implemented in practice. No information 
on the number of patients who refused to participate was 
registered and therefore the response rate is unknown. 
Consequently, no conclusions can be drawn regarding 
patients’ general willingness to participate in a study on 
medication waste. Furthermore, pharmacy visitors may 
not be representative of the general population; however, 
they may well reflect the most likely people to receive 
returned medication. Lastly, patients who returned 
medication to community pharmacies for disposal were 
interviewed (n=142, 6.4%) and were found more willing 
to use redispensed medication compared with patients 
who answered in writing. These patients may have given 
what they considered to be socially desirable answers, and 
were briefly informed on the potential consequences of 
medication waste. Additionally, these patients may be 
more willing to discuss medication waste and possibilities 
for redispensing than patients who refused to participate, 
which may overestimate the outcomes.
COnClusIOns
A substantial proportion of patients are willing to use 
medication returned unused to the pharmacy by another 
patient when the quality is guaranteed, suggesting that 
implementation of redispensing may be supported by 
patients.
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